Danimer Scientific Inc (NYSE: DNMR) stock fell -9.79% on Monday to $1.29 against a previous-day closing price of $1.43. With 1.32 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.78 million shares. During the session, the Specialty Chemicals company that operates in wider Basic Materials sector, reached to the highest price of $1.4400 whereas the lowest price it dropped to was $1.2800. The 52-week range on DNMR shows that it touched its highest point at $4.59 and its lowest point at $1.32 during that stretch. It currently has a 1-year price target of $3.00. Beta for the stock currently stands at 1.40.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of DNMR was down-trending over the past week, with a drop of -12.24%, but this was down by -21.82% over a month. Three-month performance dropped to -37.07% while six-month performance fell -61.38%. The stock lost -54.58% in the past year, while it has lost -27.93% so far this year. A look at the trailing 12-month EPS for DNMR yields -1.41 with Next year EPS estimates of -1.25. For the next quarter, that number is -0.33. This implies an EPS growth rate of -14.03% for this year and 5.29% for next year.
Float and Shares Shorts:
At present, 101.80 million DNMR shares are outstanding with a float of 89.54 million shares on hand for trading. On Oct 30, 2023, short shares totaled 14.16 million, which was 13.88% higher than short shares on Sep 28, 2023. In addition to Mr. Stephen E. Croskrey as the firm’s CEO & Chairman of the Board, Mr. Michael A. Hajost serves as its Chief Financial Officer.
Through their ownership of 39.45% of DNMR’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 24.19% of DNMR, in contrast to 19.03% held by mutual funds. Shares owned by individuals account for 14.95%. As the largest shareholder in DNMR with 5.19% of the stake, BlackRock Fund Advisors holds 5,298,518 shares worth 5,298,518. A second-largest stockholder of DNMR, The Vanguard Group, Inc., holds 4,952,564 shares, controlling over 4.85% of the firm’s shares. Teramo Advisors LLC is the third largest shareholder in DNMR, holding 3,565,000 shares or 3.49% stake. With a 2.86% stake in DNMR, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 2,920,239 shares are owned by the mutual fund manager. The iShares Russell 2000 ETF, which owns about 2.03% of DNMR stock, is the second-largest Mutual Fund holder. It holds 2,071,978 shares valued at 2.96 million. Invesco Funds – Global Consumer T holds 1.71% of the stake in DNMR, owning 1,746,900 shares worth 2.5 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for DNMR since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With DNMR analysts setting a high price target of $3.75 and a low target of $2.00, the average target price over the next 12 months is $3.00. Based on these targets, DNMR could surge 190.7% to reach the target high and rise by 55.04% to reach the target low. Reaching the average price target will result in a growth of 132.56% from current levels.
Summary of Insider Activity:
Insiders traded DNMR stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 2 while that of sell transactions has risen to 12 over the past year. The total number of shares bought during that period was 73,023 while 160,457 shares were sold.